Immediate Impact

3 from Science/Nature 63 standout
Sub-graph 1 of 20

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Polymeric Nanoparticles for Drug Delivery
2024 Standout
2 intermediate papers

Works of Gary A. Johnson being referenced

A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies
2015
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival
2008

Author Peers

Author Last Decade Papers Cites
Gary A. Johnson 510 219 389 28 1.1k
Monique Bertrand 207 199 238 72 1.1k
William J. Lowery 472 155 622 38 1.3k
S. Makinoda 388 196 305 67 1.2k
Mark Heywood 510 164 492 43 1.0k
Renate Schulze‐Rath 757 171 726 29 1.3k
Guillermo López García 509 166 513 86 1.1k
Katina Robison 342 256 440 71 1.1k
Shin‐Wha Lee 470 243 454 75 1.1k
Ann K. Folkins 531 209 814 53 1.3k
Nita K. Lee 482 148 277 37 1.0k

All Works

Loading papers...

Rankless by CCL
2026